Robert Golbey
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
- Surgery top 10%
- Testicular diseases and treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 4
- Oncology 10
- Lung Cancer Research Studies 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- Harry GrabstaldWillet F. WhitmoreEsteban CvitkovicFlorence C. H. ChuM.A. BatataBasil S. HilarisA YagodaEdgar Cheng
- Journals
- Cancer (5 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Recent results in cancer research (2 papers)Urology (1 paper)Lung Cancer (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Robert Golbey
25 papers receiving 596 citations
Peers
Comparison fields: 5 of 69
- Reproductive Medicine 86
- Surgery 347
- Hematology 69
- Oncology 168
- Hepatology 41
Countries citing papers authored by Robert Golbey
This map shows the geographic impact of Robert Golbey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Golbey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Golbey more than expected).
Fields of papers citing papers by Robert Golbey
This network shows the impact of papers produced by Robert Golbey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Golbey. The network helps show where Robert Golbey may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Golbey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 11 | |
| 2 | Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin. | 1987 | 26 |
| 3 | 1983 | 16 | |
| 4 | 1982 | 22 | |
| 5 | 1982 | 25 | |
| 6 | 1982 | 15 | |
| 7 | Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. | 1982 | 17 |
| 8 | Phase II study of methyl-GAG in the treatment of esophageal carcinoma. | 1982 | 6 |
| 9 | Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer. | 1981 | 5 |
| 10 | 1980 | 106 | |
| 11 | 1980 | 21 | |
| 12 | 1980 | 37 | |
| 13 | Vindesine in the treatment of esophageal carcinoma: a phase II study. | 1979 | 32 |
| 14 | 1979 | 42 | |
| 15 | Chemotherapy of mediastinal germ cell tumors. | 1979 | 16 |
| 16 | 1979 | 0 | |
| 17 | Intensive chemotherapy with high dose cyclophosphamide and methotrexate with citrovorum rescue in advanced lung cancer | 1977 | 1 |
| 18 | 1977 | 19 | |
| 19 | 1970 | 1 | |
| 20 | 1970 | 16 |
About Robert Golbey
Robert Golbey is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Biotechnology and Surgery, having authored 27 papers that have together received 666 indexed citations. Recurring topics across this work include Testicular diseases and treatments (9 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer therapeutics and mechanisms (6 papers), Lung Cancer Research Studies (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Neuroblastoma Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Reproductive Medicine (86 citations), Surgery (347 citations), Hematology (69 citations), Oncology (168 citations) and Hepatology (41 citations). Robert Golbey has collaborated with scholars based in United States and Germany. Frequent co-authors include Harry Grabstald, Willet F. Whitmore, Esteban Cvitkovic, Florence C. H. Chu, M.A. Batata, Basil S. Hilaris, A Yagoda, Edgar Cheng, Irwin H. Krakoff and Herbert F. Oettgen. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics, Recent results in cancer research, Urology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.